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The Hox11 paralogous genes play critical roles in kidney development. They are expressed in the early metanephric mesenchyme and are
required for the induction of ureteric bud formation and its subsequent branching morphogenesis. They are also required for the normal
nephrogenesis response of the metanephric mesenchyme to inductive signals from the ureteric bud. In this report, we use microarrays to perform a
comprehensive gene expression analysis of the Hoxa11/Hoxd11 mutant kidney phenotype. We examined E11.5, E12.5, E13.5 and E16.5
developmental time points. A novel high throughput strategy for validation of microarray data is described, using additional biological replicates
and an independent microarray platform. The results identified 13 genes with greater than 3-fold change in expression in early mutant kidneys,
including Hoxa11s, GATA6, TGFbeta2, chemokine ligand 12, angiotensin receptor like 1, cytochrome P450, cadherin5, and Lymphocyte antigen
6 complex, Iroquois 3, EST A930038C07Rik, Meox2, Prkcn, and Slc40a1. Of interest, many of these genes, and others showing lower fold
expression changes, have been connected to processes that make sense in terms of the mutant phenotype, including TGFbeta signaling, iron
transport, protein kinase C function, growth arrest and GDNF regulation. These results identify the multiple molecular pathways downstream of
Hox11 function in the developing kidney.
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The kidney is an excellent model system for studying the
principles of organogenesis. The developing kidney exhibits
many interesting processes, including establishment of an early
metanephric field by tissue interactions, budding, reciprocal
inductive interactions between ureteric bud (UB) and meta-
nephric mesenchyme (MM), stem cell growth and differentia-
tion, and conversion of mesenchyme into epithelia. In addition,
there is branching morphogenesis, apoptosis, fusion (nephrons
to collecting ducts), and proximal–distal segmentation along
the length of the nephron [for review, see (Davies and Bard,
1998)]. Metanephric, or adult, kidney development begins in⁎ Corresponding author. Fax: +1 513 636 4317.
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doi:10.1016/j.ydbio.2006.02.023the mouse at around embryonic day 11.0 (E11.0) as the UB
grows from the nephric duct and invades the MM. The UB
induces the cells of the MM to condense, epithelialize, and form
renal vesicles, each of which develops into a functional nephron
containing a glomerulus, proximal tubule, loop of Henle and
distal tubule. Of particular importance, kidney morphogenesis
can be readily studied in organ culture (Saxen and Lehtonen,
1987).
We have made significant advances in understanding the
genetic regulation of kidney organogenesis (Bouchard, 2004;
Yu et al., 2004). Hox genes play important roles in this process.
These transcription factor-encoding genes often occupy high
level positions in the genetic hierarchy of development. It is
interesting that a total of 27 Hox genes show specific domains
of expression in the developing kidney (Patterson and Potter,
2004). Mutations in the Hoxa11, Hoxc11 and Hoxd11 closely
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functions in several aspects of kidney development (Davis et al.,
1995; Patterson et al., 2001; Wellik et al., 2002). These three
genes are expressed in the early MM, and the combined
mutation of all three gives a loss of GDNF synthesis and failure
of the UB to form (Wellik et al., 2002). A hypomorphic mutant
allele combination, with mutations in Hoxa11 and Hoxd11 but
not Hoxc11, results in a MM that does not properly drive
branching morphogenesis of the UB, and in turn does not
respond correctly to UB signals (Patterson et al., 2001). These
results indicate that the Hox11 paralogs play crucial roles in
several stages of kidney development. There are still important
gaps, however, in our understanding of the downstream genetic
pathways regulated by these Hox genes.
The microarray is a useful tool for gaining deeper insight into
the genetic program of kidney development. Microarrays can
provide an important gene discovery function, identifying all
genes expressed in the developing kidney and cataloging
changes that occur over time. In addition, they allow an
impartial global view of altered gene expression profiles in
mutant developing kidneys. Instead of looking at just a few
selected marker genes by in situ hybridization, it is now possible
to conduct an unbiased and universal analysis of gene
expression patterns in mutants.
In this paper, we extend the previous microarray studies of
normal kidney development, and then use this wild type
baseline to analyze the altered gene expression patterns of the
Hoxa11/Hoxd11 mutant kidney. We used Affymetrix MOE430
oligonucleotide microarrays to examine gene expression
profiles of the complete normal kidney at E12.5, E13.5, E16.5
and adult. In addition, we determined the gene expression
patterns of the E11.5 MM and UB, using both laser capture
microdissection and manual microdissection to isolate tissues,
thereby identifying over 1500 genes with strong differential
expression. These results serve to identify the gene expression
networks and signaling pathways active in these kidney pri-
mordia. Finally, we performed an extensive microarray dissec-
tion of the altered gene expression patterns present in Hoxa11/
Hoxd11 double mutant kidneys. Several developmental time
points were examined, including E11.5, E12.5, E13.5 and
E16.5. To allow a more robust microarray analysis of the
mutant differences we combined independent data from the
Affymetrix and Illumina microarray platforms. The results
identify a battery of downstream genes that provide deeper
insight into the molecular mechanisms of Hox11 function in
kidney development.
Methods
Breeding and genotyping Hoxa11/Hoxd11 mutant mice
Hoxa11 and Hoxd11 mutant mice were previously described (Davis et al.,
1995; Patterson et al., 2001; Small and Potter, 1993). The colony was
maintained on a mixed genetic background of four strains of mice (129, C57,
C3H and CF1). Hoxa 11+/−, Hoxd11+/− double heterozygous female mice have
uterine defects that severely limit reproductive capacity (Hsieh-Li et al., 1995).
We therefore isolated zygotes from double heterozygote crosses, with super-
ovulated females, and transferred them to pseudo-pregnant surrogate wild type
CD-1 females (Nagy, 2003). Noon of the day when the vaginal plug wasobserved was considered embryonic day 0.5 (E0.5). All mice and embryos were
genotyped as previously described (Patterson et al., 2001). This study focuses on
Hoxa11, Hoxd11 double homozygous mutant mice.
Tissue dissections
Wild type tissues from E12.5 and older were obtained from outbred
CD-1 mice. Whole embryonic kidneys and urogenital ridges were dissected
in ice-cold PBS then either frozen at −80°C, or quick-frozen in Tissue-Tek®
OCT compound (Sakura, Torrence, CA) using liquid nitrogen cooled 2-
methylbutane. MM and UBs, up to T-shaped stage, were isolated by treat-
ing dissected E11.5 kidneys with 0.5 mg/ml collagenase B (Roche,
Indianapolis, IN), in D-MEM (Invitrogen, Carlsbad, CA) for 30 min at 37°C
and carefully dissecting the mesenchyme from the UB, followed by storage at
−80°C.
Laser-capture microdissection
E11.5 whole embryos were frozen in OCT. For later time points the kidneys
were removed and frozen in OCT. Serial sections (7μ) were made using a
Microm HM 550 cryostat (Richard-Allan Scientific, Kalamazoo, MI), collected
on Fisher Superfrost plus precleaned slides (Hampton, NH), and stored at
−80°C. Alternate sections were hematoxylin and eosin stained and used to help
identify the UB and MM. For LCM, the remaining sections were air dried at
room temperature for 3 min, acetone fixed for 2 min, rinsed in ice cold 1/10 PBS
for 3 min and then dehydrated in 75%, 95%, 100%, 100% ethanol, followed by
two 5-min rinses with xylene. Laser capture microdissection was performed
using the Arcturus Pixcell II system, according to Arcturus protocols (Mountain
View, California).
RNA isolation and target RNA amplification
Total RNA from wild type and mutant whole kidneys was prepared using the
Stratagene Absolutely RNA Nanoprep Kit (La Jolla, CA) and amplified as
previously described (Schwab et al., 2003). Target RNAwas then hybridized to
both the MOE430A and MOE430B Genechips (Affymetrix, Santa Clara, CA).
Microarray analysis of each stage was performed in biological duplicate using
either 30 ng or 100 ng of starting total RNA.
Each microarray hybridization represented a biological replicate, using an
independent biological sample. We pooled 3–9 wild type UB for each sample,
and 2–4 MM for each sample. Mutant E11.5 MM was not pooled.
LCM RNA was prepared using the RNeasy Micro Kit (Qiagen, Valencia,
CA), with 30 ng poly-inosine carrier (Epicentre, Madison, WI) added to the RLT
buffer. Target RNA was prepared using the TargetAmp™ 2-Round aRNA
Amplification Kit 1.0 (Epicentre, Madison, WI), and hybridized to Affymetrix
MOE430_v2 microarrays.
To validate the Affymetrix results, total RNA was isolated from HoxA11/
D11 null and normal E13.5 whole kidneys or E11.5 MM, amplified using the
Epicentre TargetAmp™ 2-Round aRNA Amplification Kit (Madison, WI) and
hybridized to Sentrix MouseRef-8 Beadchip microarrays (Illumina, San Diego,
CA) containing over 24,000 probes.
Gene expression profile analysis
Affymetrix raw data in the CEL file format was normalized using RMA
Express 0.2 (Bolstad et al., 2003) and analyzed using Genespring 7.0. Illumina
raw signal data was imported into the Affymetrix MOE430 genome on basis of
gene symbol for analysis. Wild type whole developing kidney samples were
normalized to adult samples. Normal E11.5 MM samples were normalized to
E11.5 UB. HoxA11/D11 null samples were normalized to the corresponding
wild type control. Hierarchical clusters were generated using the Pearson
Correlation Function. All microarray data are available from Signet (http://
cypher.cchmc.org:1104/servlet/GeNet, login as “Guest, select MOE430 ge-
nome, data contained in “SPotter/Schwab et al. 2005 folders”) allowing
interactive analysis of the data, through other public databases (GEO,
GUDMAP), and will be provided upon request.
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Total RNAwas obtained and DNAse 1 treated from separate E13.5 Hoxa11/
d11 (n = 4) and control kidneys (n = 3) using Stratagene Absolutely RNA
Microprep Kit (La Jolla, CA). cDNA was generated using random hexamers
according to conventional protocols (Invitrogen, Carlsbad, Ca). The following
primers were generated specifically to the sequence obtained from the
Affymetrix probe set: Actb (TTGCTGACAGGATGCAGAAG, ACATCT-
GCTGGAAGGTGGAC), Cxcl12 (GTCTAAGCAGCGATGGGTTC, TAG-
GAAGCTGCCTTCTCCTG), HoxA11s (TGTCCTGGAGGAAGGAGAA,
ATCACCACCATTGGGAGGT), Pdgfrb (AGCAAGAGTGGCAGAGAAGG,
TAATCCCGTCAGCATCTTCC), Slit3 (CGTGGAAGAGGTGGAGAGAC,
AGAGGTTCCATGTGGCTGTT), and Tgfb2 (GAAATACGCCCAAGATC-
GAA, TGTCACCGTGATTTTCGTGT) using Primer3 software (Rozen and
Skaletsky, 2000). Relative quantitative PCR was performed according to the
conventional SYBR Green protocol (Stratagene) using the Stratagene Mx3000p
QPCR system. Dissociation curve and agarose gel analysis of each primer set
were used to insure specificity of the amplicon. All data were normalized to an
internal housekeeping control (Actb) and analyzed using the 2(-Delta Delta C(T))
method (Livak and Schmittgen, 2001).
Results
Microarray comparisons of gene expression profiles of wild
type E12.5, E13.5, E16.5 and adult kidneys
We used Affymetrix MOE430 microarrays to examine gene
expression patterns of the normal developing kidney at E12.5,
E13.5, E16.5 and adult. These oligonucleotide arrays carry over
48,000 probe sets and monitor expression levels of over 20,000
genes. A high stringency analysis of the data identified 2793
genes that showed a strong change in expression level as a
function of developmental time. The heat map in Fig. 1Fig. 1. Heat map showing 2793 genes clustered according to expression during
kidney development. Developmental times include E12.5, E13.5, E16.5 and
adult. Expression levels were normalized to the adult kidney. Red shows
elevated, blue indicates reduced, and yellow shows unchanged expression. Only
genes with greater than 3-fold change are included. Complete gene lists and
analysis tools are available online (see Methods).illustrates the patterns observed. The gene expression profiles of
E12.5 and E13.5 kidneys were very similar, while at E16.5 a
significant block of genes showed altered expression. Expres-
sion levels were normalized to that of the adult kidney, shown in
the right two lanes. All data and gene lists are available from the
Signet server (see Methods).
Gene expression profiles of the E11.5 MM and UB
The MM and UB represent the embryonic precursors of the
adult kidney. At E11.5, the UB has invaded the MM. A series of
reciprocal inductive interactions drive the mesenchyme to
convert to epithelia and form nephrons, while the bud
undergoes branching morphogenesis and forms the collecting
ducts.
To better understand the distinct properties of the UB and
MM, we defined their gene expression profiles. The UB is a
discrete structure and was cleanly purified by manual
microdissection following enzymatic treatment to dissociate
the surrounding mesenchyme. The MM, with a more poorly
defined outer border at this stage of development, was isolated
by both manual microdissection and by laser capture microdis-
section. To provide a UB-MM comparison with great statistical
power, we examined a total of four UB and seven MM
biological replicates.
The resulting microarray data showed a high degree of
reproducibility. The scattergraph in Fig. 2A compares the gene
expression patterns of two MM samples purified by laser
capture microdissection. If each gene showed exactly the same
expression in both samples there would be a single line at 45
degrees. There is some scatter, with about 1% (526) of the
>48,000 probe sets giving more than a 3-fold difference (green
lines) in expression level between the two samples. This is
likely due to a combination of biological variation, sampling
error during LCM, and noise resulting from the two round target
amplification procedure required because of the small amount
of starting RNA. This noise is eliminated in the analysis by
examining multiple biological replicates and requiring consis-
tent change. Fig. 2B compares MM isolated by LCM versus
mesenchyme isolated by manual microdissection, showing a
similar level of scatter to that seen in Fig. 2A. Interestingly,
there was significantly less scatter in pair-wise comparisons of
UB samples (Fig. 2C), with less than 0.1% of probe sets (56)
showing over a 3-fold difference in expression level. Most
striking, however, was the large number of genes with dramatic
differences in expression when comparing the UB and MM
(Fig. 2D).
A stringent analysis of the UB and MM microarray data was
performed. Using rigorous criteria requiring an average fold
change of at least three, with Benjamini and Hochberg false
discovery rate multiple testing correction, and a t test ofP < 0.05,
we identified 1518 differently expressed genes. This is illus-
trated in the heat map of Fig. 3. These numbers are higher than
previously reported (Schwab et al., 2003) because of improved
purification protocols, more comprehensive microarrays, and
the use of a considerably larger number of microarrays (11 vs. 4),
lending greater statistical power to the analysis.
Fig. 2. Scattergraphs of E11.5 UB andMMmicroarray data. (A) Biological replicates of E11.5 MM purified by LCM. (B) Comparison of manually dissected and LCM
isolated E11.5 MM. (C) Biological replicates of manually dissected E11.5 UB. (D) Comparison of UB and MM samples. Note the good reproducibility of MM data,
whether isolated by manual microdissection or LCM, and the still higher reproducibility of the UB data. The MM-UB comparison, in contrast, shows striking
differences. Green lines mark the 3-fold difference boundary. Each dot represents one probeset that has been called by the GCOS software as “Present” in each
microarray, except in D in which at least one probeset must be called “Present.”
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identifies many interesting genes not previously implicated in
early kidney development. In addition, 63 genes that have been
previously shown to exhibit restricted UB or MM expression
are found on the list of 1518 genes. These genes are included in
Table 1 along with references documenting discrete expression.
Of interest, in each case the microarray data is consistent with
the previous expression study. This universal agreement of the
microarray data with previous in situ hybridization studies
provides an important measure of validation. The UB-MM
specific expression patterns of GDNF, Ret, Hoxa11, Hoxc10,
Hoxd10, Hoxa10, Wnt9b, Wnt4, Wnt11, Six2, Wt1, Foxc1,
Lhx1 and 50 other genes were all correctly called by the
microarrays. In addition, Table 1 lists other selected genes
ranked according to fold difference in expression. These genes
encode cytokines, receptors, and several categories of tran-
scription factors and growth factors, of potential importance in
programming the early functions of these two structures.
Analysis of Hoxa11/d11 mutant kidneys
This microarray atlas of gene expression patterns in the
normal developing kidney provides a baseline that can be used
for the global analysis of altered gene expression patterns inmutants. Previous studies have shown that the Hox11
paralogous genes play important, yet redundant roles in several
phases of kidney development (Davis et al., 1995; Patterson et
al., 2001; Wellik et al., 2002). To better understand the
molecular level perturbations present in the mutant kidneys,
we performed an exhaustive microarray analysis. We focused
on the Hoxa11/Hoxd11 double homozygous mutant. These
mice show a severe kidney phenotype, with reduced branching
morphogenesis of the collecting duct system and altered gene
expression patterns, as defined by in situ hybridization, during
nephrogenesis (Patterson et al., 2001). Further removal of the
Hoxc11 gene results in very early arrest of kidney development
(Wellik et al., 2002), precluding the study of later developmen-
tal functions of this gene group.
E12.5/E13.5 wild type-Hoxa11/d11 mutant comparison
Our first comparisons of wild type and Hoxa11/d11 mutant
used Affymetrix MOE430 microarrays and examined E12.5,
E13.5 and E16.5 developmental time points, each in biological
duplicate. As might be expected, the gene expression profiles of
the wild type and Hoxa11/d11 mutant kidneys were much more
similar than seen for the wild type UB-MM comparison.
Lowering the stringency of the analysis to find the lower fold
Fig. 3. Heat map showing 1518 genes clustered according to differential
expression in E11.5 UB andMM. TheMM expression levels were normalized to
UB. The upper blue cluster represents 800 genes with decreased expression in
the MM. The lower red cluster shows 718 genes with higher expression levels in
the MM. Note the high reproducibility of the expression differences across all
samples.
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many artifact difference calls, as shown by real time PCR
validation (data not shown).
To improve the discriminatory power of the study, we
repeated the microarray analysis of the E13.5 wild type and
mutant kidneys, this time using the Illumina beaded array
platform. This provided additional microarray data, making the
statistical comparison stronger, and it added more biological
samples, as biological replicates were performed, further
helping to remove biological noise. In addition, it gave a new
microarray perspective, since an independent microarray
system was used. Three normal and two mutant E13.5 kidneys
were examined with Illumina. This gave a total of nine
microarrays for the E13.5 comparison, with five Illumina and
four Affymetrix. These data were analyzed with GeneSpring
7.0, setting the screen parameters at non-parametric test (Welch
t test) P < 0.05, using Benjamini and Hochberg multiple testing
correction, fold change >1.5, and a minimum raw expression of
400 in at least two samples to remove genes with very low
expression levels. This resulted in a list of 467 genes
(Supplementary Figure S1).
To further strengthen the analysis, we combined the data
from the wild type-mutant comparisons at E12.5 and 13.5.
These two time points showed similar wild type gene
expression profiles (Fig. 1). A comparable stringency
analysis of the E12.5 data was performed, using four
Affymetrix MOE430 microarrays, and deleting the multiple
testing correction, because of the smaller number of
microarrays used. The resulting gene list was used todetermine the set of overlapping genes, with different
expression levels in both the E12.5 and E13.5 wild type
versus mutant comparisons. This gave a list of 122 probe
sets, representing 107 different genes (Table 2), with relative
expression levels in the 17 microarrays shown in the heat
map of Fig. 4. These genes gave consistent expression level
differences in both the E12.5 and E13.5 wild type versus
mutant comparisons. In addition, many showed similar
expression changes in the E16.5 wild type and mutant
kidneys (Fig. 4).
It is interesting that the gene showing the greatest change
in expression in the Hoxa11/d11 mutants was the Hoxa11
antisense transcript. We have previously shown that the
Hoxa11 gene gives rise to both sense and antisense transcripts
(Hsieh-Li et al., 1995). The targeting of the Hoxa11 gene
created a deletion including the homeobox region (Small and
Potter, 1993), which clearly reduced antisense transcription.
The Affymetrix microarrays also identified a significant
reduction of Hoxa11 sense transcripts in the mutants (−6.3-
fold at E12.5, −6.4 at E13.5 and −5.8 at E16.5). This
difference, however, was not detected by the Illumina
microarrays, which reported very low expression of Hoxa11
even in the wild type (raw signals of 70 to 160), so this gene
did not make the final list. This illustrates that the two
microarray platforms show gene specific detection differ-
ences. In general, we observed that both platforms provided
excellent concordant expression level analysis for most genes.
But a few genes were better assayed by one system, and other
genes by the other. By requiring both types of microarrays to
observe a change it is clear that some genuine expression
changes, such as the Hoxa11 sense transcript, will be lost.
The Hoxd11 gene was targeted in a different manner, not by
deletion but by the insertion of a Neo selectable marker.
Neither microarray system found a change in expression level
of this gene, suggesting that the insertion did not significantly
alter transcript abundance.
It is also interesting to note that 15 of the genes called
differently expressed are represented by duplicate probe sets
on the Affymetrix microarrays. That is, the probe set list of
122 includes only 107 different genes. The fold changes
called by these independent probes sets in this combined data
set show excellent agreement. These include, in alphabetical
order, angiotensin receptor like-1 (fold changes of 2.5, 3.1),
carbonic anhydrase 4 (−1.9, −2.1), elastin microfibril
interfacer 1 (2.2, 2.2), EST AI450540 (1.6, 2.2), Fibrillin 1
(2.5, 2.0), GATA6 (3.9, 3.0), high mobility group box 1
(−1.6, −1.8), insulin-like growth factor binding protein 4 (2.0,
1.8), Lipoma HMGIC fusion partner-like 2 (1.7, 1.6),
mastermind like 1 (2.3, 1.7), pdgf receptor beta (2.6, 2.1),
Procollagen, type V, alpha 1 (2.5, 1.9), Procollagen, type
XVIII, alpha 1 (2.3, 2.0), Procollagen, type XXIII, alpha 1
(2.3, 2.0).
To further test the validity of the resulting gene list we
performed real time PCR for five genes. The results are shown
in Fig. 5. For all five genes a significant difference in gene
expression was confirmed, in the direction predicted by
microarrays. The fold change agreement between microarray
Table 1
Select transcription factor or signaling pathway transcripts ranked by average fold difference between the E11.5 MM and UB
Gene
name
MM or UB
enrichment
Fold
change
Reference Gene name MM or UB enrichment Fold change Reference
Foxd1 MM 81.3 (Hatini et al., 1996) Pou3f3 UB 52.9
Hoxc10 MM 71.4 (Patterson and Potter, 2004) Crlf1 UB 41.0 (Schmidt-Ott et al., 2005)
Hoxd10 MM 61.3 (Patterson and Potter, 2004) Cdh1 UB 29.6 (Klein et al., 1988)
Meis1 MM 57.1 Emx2 UB 27.8 (Miyamoto et al., 1997)
Gdnf MM 51.5 (Moore et al., 1996; Pichel et al., 1996;
Sanchez et al., 1996)
Calcr UB 27.5
Eya1 MM 49 (Kalatzis et al., 1998) Sostdc1 UB 24.9 (Schmidt-Ott et al., 2005)
Isl1 MM 47.4 Lhx1 UB 22.5 (Kobayashi et al., 2005)
Eya4 MM 46.5 Cdh16 UB 20.2
Pdgfra MM 45.5 (Seifert et al., 1998) Wnt9b UB 18.8 (Carroll et al., 2005;
Kobayashi et al., 2005)
Itga8 MM 45 (Muller et al., 1997) Itk UB 18.1
Sall1 MM 44.6 (Nishinakamura et al., 2001) Elf5 UB 15.5
Tgfbi MM 38.2 (Schwab et al., 2003) Sim1 UB 15.3
Foxc2 MM 38 (Kume et al., 2000b) Fgfr4 UB 14.8 (Stark et al., 1991)
Hoxa10 MM 37.9 (Patterson and Potter, 2004) Npnt UB 14.4 (Brandenberger et al., 2001)
Tbx18 MM 35.2 Ros1 UB 13.8 (Tessarollo et al., 1992)
Tcf21 MM 33.3 (Quaggin et al., 1999) Tcf2 UB 13.6
Hoxa9 MM 32.1 (Patterson and Potter, 2004) Tbx3 UB 13.1
Hoxc8 MM 28.4 (Patterson and Potter, 2004) Gata3 UB 12.1 (Labastie et al., 1995;
Lim et al., 2000)
Foxc1 MM 24.9 (Kume et al., 2000b) Igfbp1 UB 11.0
Csf1r MM 24.9 Irf6 UB 10.6
Agtr2 MM 24 Igfbp2 UB 10.4 (Schmidt-Ott et al., 2005)
Wt1 MM 20.8 (Kreidberg et al., 1993; Ryan et al., 1995) Wnt6 UB 10.1 (Itaranta et al., 2002)
Twist2 MM 17.8 Shh UB 10.0 (Yu et al., 2002)
Foxp2 MM 16 Hoxd1 UB 9.4 (Patterson and Potter, 2004)
Prrx1 MM 15.7 Lama1 UB 9.2 (Schmidt-Ott et al., 2005)
Frzb MM 13.8 Cxcl14 UB 9.1 (Schmidt-Ott et al., 2005)
Meox2 MM 13.3 Tcf7 UB 8.5
Cdh11 MM 12.7 (Cho et al., 1998) Fgf12 UB 8.4
Hand2 MM 12.5 Mia1 UB 7.9 (Schwab et al., 2003)
Six2 MM 12.5 (Oliver et al., 1995) Socs2 UB 7.8
Meox1 MM 12.1 (Candia et al., 1992) Tnfrsf19 UB 7.4
Pdgfrb MM 11.4 (Seifert et al., 1998) Klf5 UB 7.4
Cart1 MM 11.4 Sema4d UB 7.3
Hoxa11s MM 10.7 (Hsieh-Li et al., 1995) Pgr UB 6.8
Reln MM 10.6 Ret UB 6.7 (Durbec et al., 1996;
Schuchardt et al., 1994)
Wnt4 MM 9.3 (Kispert et al., 1998; Stark et al., 1994) Wnt11 UB 6.7 (Majumdar et al., 2003)
Nr2f2 MM 8.8 Kitl UB 6.6 (Schmidt-Ott et al., 2005)
Bmp4 MM 8.7 (Miyazaki et al., 2000) Epha1 UB 6.3
Gata6 MM 8.6 Fzd5 UB 6.1
Twist1 MM 8.5 Sall4 UB 6.1
Itga8 MM 8.3 (Muller et al., 1997) Fzd6 UB 6.1
Tgfb2 MM 8.1 (Plisov et al., 2001) Sox6 UB 6.0
Cxcl4 MM 8.1 Pou3f4 UB 6.0
Cxxc4 MM 7.9 Emb UB 5.9 (Fan et al., 1998)
Igf1 MM 7.8 Lama5 UB 5.7
Calcrl MM 7.3 Sema3c UB 5.7
Hoxc4 MM 6.7 (Patterson and Potter, 2004) Tbx2 UB 5.6
Ace2 MM 6.4 Fstl5 UB 5.3
Tbx18 MM 6.2 Spry1 UB 5.3 (Basson et al., 2005)
Tgfb3 MM 6 Fzd8 UB 5.1
Cxcl7 MM 5.8 Irx3 UB 4.8
Foxd2 MM 5.5 (Kume et al., 2000a) Cdh3 UB 4.7
Tek MM 5.4 Sema4f UB 4.7
Tgfb1i1 MM 4.8 (Brunskill et al., 2001) Tgfa UB 4.7
Itga6 MM 4.8 Bspry UB 4.6
Prrx2 MM 4.8 Cd9 UB 4.6
Tie1 MM 4.6 (Loughna et al., 1997) Neuregulin 3 UB 4.5
Cxcl12 MM 4.6 Hoxd8 UB 4.5 (Patterson and Potter, 2004)
(continued on next page)
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Table 1 (continued)
Gene
name
MM or UB
enrichment
Fold
change
Reference Gene name MM or UB enrichment Fold change Reference
Hoxa11 MM 4.4 (Patterson and Potter, 2004) Sema5b UB 4.4
Ebf2 MM 4.4 Gfra1 UB 4.4 (Enomoto et al., 1998)
Gfra3 MM 4.4 Hoxb7 UB 4.4 (Patterson and Potter, 2004)
Ccl19 MM 4.1 Dkk1 UB 4.4
Tbx1 MM 3.9 Myb UB 4.3
Fgfr3 MM 3.8 En2 UB 4.2
Gli1 MM 3.8 Lamc1 UB 4.1 (Virtanen et al., 1995)
Cxcl13 MM 3.7 Cyr61 UB 3.9 (Schmidt-Ott et al., 2005)
Slit3 MM 3.7 (Piper et al., 2000) Mal UB 3.8
Ccl6 MM 3.7 Lhx8 UB 3.7
Slit3 MM 3.7 Itga3 UB 3.7
Hoxc9 MM 3.6 (Patterson and Potter, 2004) Slit2 UB 3.6 (Grieshammer et al., 2004)
Pbx1 MM 3.6 (Schnabel et al., 2003) Fzd4 UB 3.6
Pbx3 MM 3.5 Sema6a UB 3.6
Sfrp1 MM 3.2 (Yoshino et al., 2001) Cklfsf8 UB 3.5
Eya2 MM 3.2 Cxcr4 UB 3.4
Notch4 MM 3.1 Sema5a UB 3.4
Sfrp2 MM 3.1 Cited4 UB 3.3
Hoxd11 MM 3.1 (Patterson et al., 2001) Sema3d UB 3.2
Ccr1 MM 3.1 Sema3b UB 3.1
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2.8, TGFbeta2, 3.6 vs. 3.3, pdgfrb, 2.1 vs. 1.5), although for two
genes the real time PCR found a much greater fold change than
the microarrays (Slit3, 2.3 vs. 7.8, Hoxa11antisense, −5 vs.
−34). These results suggest that by using a combined 17Fig. 4. Heatmap showing122genes clustered according to differential expression
in wild type and Hoxa11/Hoxd11 mutant kidneys. Expression levels were
examined at E12.5, E13.5 andE16.5. Geneswere selected by average fold change
>1.5 at both E12.5 and E13.5, using both Affymetrix and Illumina microarray
platforms (see text for details). All mutant expression levels were normalized to
the corresponding microarray platform's wild type expression. Red indicates
increased, blue indicates decreased and yellow shows unchanged expression.
Most of the differences seen at E12.5 and E13.5 were also present at E16.5microarrays, including two different platforms and examining
two closely related developmental stages, it was possible to
discern a list of genes with genuine expression differences in
wild type and Hoxa11/d11 mutant kidneys.
The microarray data called eight genes with greater than 3-
fold change in expression in the mutants. These are quite
interesting genes, (GATA6, TGFbeta2, chemokine ligand 12,
angiotensin receptor like 1, cytochrome P450, cadherin5,
Hoxa11 antisense and Lymphocyte antigen 6 complex),
encoding a transcription factor, a growth factor, a chemokine,
a receptor and a cell adhesion molecule. The bulk of genes
differently expressed, however, showed lower fold changes, in
the 1.5–3 range. We have previously shown that certain
regions of the mutant kidneys, in particular the two poles,
often show relatively normal development (Patterson et al.,
2001). The more normal gene expression patterns in theseFig. 5. QPCR validation of microarray predicted gene expression differences.
Cxcl12, HoxA11s, Pdgfrb, Slit3, and Tgfb2 were examined. Separate E13.5
mutant and wild type kidney samples were assayed in sample groups of at least
three. Graph shows mutant fold change normalized to wild type group according
to QPCR (blue bars) or microarray data (red bars). The numbers agreed well,
except for HoxAlls (HoxA11 antisense), and Slit3, where the QPCR called
larger fold changes than the microarrays.
Table 2
122 genes differentially expressed between Hoxa11/d11 null and wild type whole kidneys consistently at both E12.5 and E13.5
Gene name Fold change Gene name Fold change Gene Fold change
Gata6 3.9 BC039093 2 Tfip11 1.6
Tgfb2 3.6 Ptk2 2 Eps15-rs 1.6
Cxcl12 3.3 Sox18 2.1 Plcd1 1.5
Agtrl1 3.1 Eml1 2.1 AA408278 1.5
Cyp26b1 3.1 Igfbp4 2 Rbm4 −1.5
Cdh5 3.1 Col3a1 2 2010005O13Rik −1.5
Gata6 3 Col18a1 2 Ptplb −1.6
Sepn1 2.8 Col23a1 2 Rab25 −1.6
Rgs12 2.8 Fbn1 2 0610007A15Rik −1.6
Tsc2 2.8 2310014H19Rik 2 Timm13a −1.6
Smad6 2.8 6720469N11Rik 2 Hagh −1.6
Ltbp1 2.7 Ube2r2 1.9 Ppie −1.6
Pdgfrb 2.6 Cul7 1.9 Hmgb1 −1.6
9-Sep 2.6 Ldb1 1.9 2700085M18Rik −1.6
2610001E17Rik 2.6 Col5a1 1.9 2310003L22Rik −1.7
Agtrl1 2.5 BC025600 1.9 6330548G22Rik −1.7
Fbn1 2.5 1110012D08Rik 1.9 Atp5h −1.7
Vegfc 2.5 Sidt2 1.9 Hagh −1.7
Col5a1 2.5 E130203B14Rik 1.9 Rcl1 −1.8
Sec31l1 2.5 Ephb4 1.9 Npm3 −1.8
Col4a2 2.4 Mast2 1.9 Gkap1 −1.8
Vars2 2.4 Lnk 1.9 Khdrbs1 −1.8
Sbk 2.4 1300018I05Rik 1.8 Hmgb1 −1.8
4933409N07Rik 2.4 Myo7a 1.8 1700021F05Rik −1.8
Maml1 2.3 BC004012 1.8 2410019A14Rik −1.9
Col23a1 2.3 1100001D10Rik 1.8 1700001E16Rik −1.9
Mmp11 2.3 Igfbp4 1.8 Hnrpa3 −1.9
Slit3 2.3 Zbtb5 1.8 Psma7 −1.9
Col18a1 2.3 D10Ertd610e 1.7 Car4 −1.9
Foxd1 2.3 Plekhm1 1.7 Ggt1 −2
Sulf2 2.2 Ctxn 1.7 Drg1 −2
Emilin1 2.2 Thsd1 1.7 Hcngp −2
Emilin1 2.2 BC033915 1.7 Hnrpdl −2.1
AI450540 2.2 Lhfpl2 1.7 Pmvk −2.1
Actr1a 2.2 Anxa6 1.7 Car4 −2.1
Robo4 2.2 Maml1 1.7 Hsd17b7 −2.2
Islr 2.1 Zdhhc7 1.6 Nudt5 −2.2
Bace1 2.1 Lhfpl2 1.6 Fkbp2 −2.4
4732495E13Rik 2.1 Inpp5e 1.6 Ly6a −3.7
Pdgfrb 2.1 Nsg2 1.6 Hoxa11s −5.1
6530411B15Rik 2 AI450540 1.6
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in the severely developmentally perturbed ventral–medial part
of the mutant kidney. It is likely, therefore, that our results
represent underestimates of the fold changes present in the
most abnormal regions.
Comparison of wild type and Hoxa11/d11 mutant E11.5 MM
The E11.5 time point is of particular interest in the analysis
of the Hoxa11/d11 mutants. Both Hoxa11 and Hoxd11 are
expressed in the E11.5 MM, and at this early stage the MM
appears histologically normal. Nevertheless it is functionally
deficient. In some mutants with severe phenotypes we have
observed that the UB forms, and penetrates the MM. However,
instead of stopping and branching the UB simply grows right
through the MM, exiting the other side (Patterson, unpublished
observations). The Hoxa11/d11 genes clearly play an important
role in communication between the early UB and MM.To perform a global analysis of the altered gene expression
pattern in the E11.5 MM we used a strategy similar to that
described for the E12.5/E13.5 wild type-mutant comparison. To
improve purity of starting material, we used laser capture
microdissection to isolate MM from wild type and mutant E11.5
embryos. Following RNA purification and two round in vitro
transcription target amplification, we used the Affymetrix
MOE430 microarrays to determine gene expression levels. To
achieve high throughput validation of the resulting gene list, we
then repeated this process, using the Illumina platform, looking
for genes consistently called differently expressed in wild type
and mutant E11.5 MM by both systems. Each microarray used
an independent biological sample (biological replicate). Again,
a total of 17 microarrays were used for the comparison, in this
case with 12 Affymetrix and 5 Illumina microarrays. The data
were analyzed with GeneSpring 7.0, using similar parameters to
those described for the E12.5/E13.5 data, except with a more
stringent expression threshold cutoff. In this case we required a
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versus the cutoff of 400 used for the E12.5, E13.5 data. Genes
with low expression levels give low signal to noise ratios and
are a major source of artifacts. In both sets of comparisons, we
eliminated the bulk of these false calls by setting stringent
minimal expression requirements.
This analysis provided a list of 146 genes showing greater
than 1.5-fold change in expression in the mutant E11.5 MM.
The consistency of these expression differences across the
seventeen samples, including both microarray platforms, is
illustrated in the series graph of Fig. 6. The gene list, with
observed fold changes, is provided in Table 3. We found six
genes with greater than 3-fold change in expression. Iroquois 3
(Irx3), encoding a homeodomain transcription factor, was up-
regulated 6-fold, and the EST A930038C07Rik was up-
regulated 3.5-fold. Down-regulated genes included Meox2
(−3.4) also encoding a homeodomain protein, Hoxa11 antisense
(−4.4), Prkcn (−4.5) encoding a protein kinase C, and Slc40a1
(−5.2, −6.1), encoding an iron transporter. In addition there are
a number of interesting genes with smaller fold expression
changes in the 1.5–3 range, some of which are discussed later.
Together, these extensive microarray studies of the altered
gene expression patterns present in the Hoxa11/d11 mutant
kidneys provide deeper insight in the normal functions of the
Hox11 group of genes, as discussed further below.
Discussion
Microarrays provide a powerful technology for the analysis
of both normal and mutant kidney development. The pioneering
work of Stuart et al. (2001) used Affymetrix microarrays toFig. 6. Log series graph of 146 genes differentially expressed between HoxA11/D
expression for these genes using both the Affymetrix and Illumina platforms. Gene
regardless of platform (see text for details). Gene in red are up-regulated and thoseexamine normal rat kidney development, identifying several
important functional groupings and thousands of specific genes
not previously associated with kidney development. This work
was subsequently extended to the developing mouse kidney
(Schwab et al., 2003). Several recent reports have taken the
microarray analysis of kidney development a step further, with
Challen et al. (2004) using cDNA arrays to define the genes
expressed specifically in the E10.5 uninduced MM, compared
to more rostral uninduced intermediate mesoderm, in order to
better define the nature of the early renal stem cell. Challen et al.
(2005) also conducted an extensive cDNA microarray analysis
of the gene expression profiles of total developing kidneys at
multiple stages, as well as GFP sorted UB at E15.5. In another
important study Schmidt-Ott et al. (2005) manually micro-
dissected UB tips and mesenchyme from both mouse (E12.5)
and rat (E13.5) and used Affymetrix microarrays to find
differentially expressed genes. Of particular interest they
identified the cytokine Clf-1 as a novel regulator secreted by
the UB. In this report we extend this growing microarray
database of normal kidney development by using the Affyme-
trix MOE430 generation microarray to determine gene
expression profiles of total kidneys at multiple stages of
development.
We also performed an extensive analysis of E11.5 MM and
UB gene expression patterns, including laser capture microdis-
section to insure tissue purity, and using a total of eleven
microarrays to provide great statistical power in the analysis.
This resulted in a comprehensive definition of the gene
expression states of these two critical early kidney components.
We identified 1518 genes with over 3-fold divergent expression,
including growth factors, cytokines, receptors, and transcription11 null and wild type E11.5 MM. This graph shows the consistent change in
s were selected on statistical significance and an average fold change of >1.5
in blue are down-regulated, as normalized to wild type.
Table 3
146 genes differentially expressed between HoxA11/D11 null and wild type E11.5 MM
Gene name Fold change Gene name Fold change Gene Fold change
Irx3 6 Sall2 −1.6 Hus1 −1.8
A930038C07Rik 3.5 Sfrs1 −1.6 2700023B17Rik −1.8
Hs3st3a1 2.7 Eif3s5 −1.6 Gtl6 −1.8
4930422J18Rik 2.4 Luc7l2 −1.6 Pfdn2 −1.8
1110055E19Rik 2.3 Yap1 −1.6 4432404J10Rik −1.8
Slc6a8 2.2 Tardbp −1.6 Pfn2 −1.8
Prcc 2 Arpp19 −1.6 Prkcn −1.8
Elovl4 1.9 1110002B05Rik −1.6 E230022H04Rik −1.8
Ccnd1 1.9 Acaa1 −1.6 Fignl1 −1.8
Ltap 1.8 Zfp292 −1.6 Gltp −1.9
Tiam1 1.8 Becn1 −1.6 Dhx15 −1.9
Tm4sf13 1.7 Tcte1l −1.6 Trim25 −1.9
Epb4.1l4a 1.7 Dazap2 −1.6 Mtf2 −1.9
Cacna1h 1.7 Casp2 −1.6 Vps54 −1.9
Sfrs2 1.7 Topors −1.6 Hnrpa1 −1.9
Tm4sf9 1.6 Gng10 −1.6 4833420G17Rik −1.9
Dbn1 1.6 Zcchc6 −1.6 D11Ertd333e −1.9
1100001I19Rik 1.6 Hoxa5 −1.6 Dhx15 −1.9
Ogt −1.5 Acaa1 −1.6 Hoxd10 −2
AW549877 −1.5 Suhw3 −1.6 Kbtbd2 −2
D16Bwg1543e −1.5 Tnrc6 −1.6 Rassf1 −2
Pole4 −1.5 AW539964 −1.6 Thsd2 −2
2700029M09Rik −1.5 Purb −1.6 Hnrpdl −2
Pygb −1.5 Tnrc6 −1.6 BC019806 −2
Sh3bgrl −1.5 Eif4a2 −1.6 Foxc2 −2
5730526G10Rik −1.5 Mrg1 −1.6 Hnrpdl −2.1
1110028E10Rik −1.5 Rps6 −1.6 Rassf1 −2.1
Zhx1 −1.5 Prkwnk1 −1.7 Eml4 −2.2
1810043J12Rik −1.5 Srp14 −1.7 1110021E09Rik −2.2
Mcm4 −1.5 Msh6 −1.7 Cul1 −2.2
Mrps33 −1.5 D11Ertd333e −1.7 Pja2 −2.2
Arf3 −1.5 Rab24 −1.7 2810485I05Rik −2.3
5930412E23Rik −1.5 6330412F12Rik −1.7 8430438D04Rik −2.4
2700023B17Rik −1.5 Qrsl1 −1.7 Kbtbd2 −2.4
1110003E01Rik −1.5 Ncoa6ip −1.7 Cox7a2l −2.4
Gtl6 −1.5 6330578E17Rik −1.7 Cox7a2l −2.4
Tbk1 −1.5 Mrg1 −1.8 Cno −2.5
5930412E23Rik −1.5 Mrpl50 −1.8 Tpm2 −2.5
Fgfr1op −1.6 Zfp68 −1.8 Shoc2 −2.5
Rhobtb3 −1.6 Tubb6 −1.8 Wsb1 −2.6
Pldn −1.6 Ibtk −1.8 Tpm2 −2.7
Pafah1b1 −1.6 Wasl −1.8 Tpm2 −2.7
Gas5 −1.6 Hus1 −1.8 Meox2 −3.4
Tardbp −1.6 2700023B17Rik −1.8 Hoxa11s −4.4
4121402D02Rik −1.6 Gtl6 −1.8 Prkcn −4.5
Ets2 −1.6 Ibtk −1.8 Slc40a1 −5.2
2610208E05Rik −1.6 Wasl −1.8 Slc40a1 −6.1
1110004P21Rik −1.6
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tions and differential development of these two tissues.
This set of data for normal kidney development then
provides the foundation for the microarray analysis of kidney
mutant phenotypes. In this study, we focused on the analysis of
the Hoxa11/Hoxd11 double homozygous mutant kidneys at
early stages of development. At E11.5, the invading UB has
branched once, forming a T-shaped structure, and the MM has
not yet formed even the earliest epithelial nephron precursor, the
renal vesicle. It is important to emphasize that in this study we
used laser capture microdissection to purify wild type and
mutant E11.5 MM for microarray analysis. A little later, atE12.5 and E13.5, the UB has undergone multiple branches and
early nephrogenesis is underway. By looking at these early
times, we increased the likelihood of finding initiating events in
the Hoxa11/Hoxd11 mutant disturbed genetic program of
kidney development. These early changes in gene expression
in the mutant can then presumably give rise to further
downstream cascade effects at later times, which might also
be interesting, but could be secondary to dramatic changes in
cell differentiation and/or relative abundances of different cell
type populations.
We found that the subtle changes in gene expression present
in the mutants at early time points were difficult to tease out
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lyzed, E11.5, and the combined E12.5/E13.5, we found it
necessary to use 17 microarrays. Of particular interest, we found
that the use of two independent microarray platforms,
Affymetrix and Illumina, coupled with independent biological
samples, greatly strengthened the study.
A key bottleneck in microarray studies is the validation
process. After the microarray data is generated and analyzed a
gene list is made. There must, however, be supporting evidence
indicating that the gene list is authentic. In this study we found
that in our initial comparisons of early wild type and mutant
embryonic kidneys, even when using as many as eight
Affymetrix microarrays, over half of the genes called differently
expressed by microarray were failing to validate by real time
PCR. Indeed, we were unable to set a stringency of analysis that
clearly distinguished the genes that validated with real time
PCR. The use of an additional microarray platform, however,
with independent biological replicates, appeared to provide an
effective high throughput validation. Genes called differently
expressed by both systems consistently validated by real time
PCR. This might be an extremely useful general validation
strategy, offering a rapid method for separating true differences
from artifacts. Instead of checking for genuine gene expression
differences one at a time by real time PCR, one uses a distinct
microarray system with new biological samples to confirm
changes en masse.
It is interesting that for the wild type-Hoxa11/d11 mutant
comparison at both E11.5 and the combined E12.5/E13.5 stages
we observed relatively few genes with greater than 3-fold
expression change. It was reassuring to find a Hoxa11 transcript
(Hoxa11 antisense) common to both lists. It was somewhat
surprising, however, to find that the two lists of differently
expressed genes had very little else in common. Our previous
molecular marker studies of these mutant kidneys indicated that
the Hox11 genes function in multiple processes at several stages
of kidney development, and these distinct gene lists could
reflect timing specific variations in function. The Hox11 genes
could be driving distinct processes at these two stages. It is also
possible that some of the observed differences at E12.5/13.5
could be the result of downstream effects of the earlier changes.
The gene showing the largest fold change in the Hoxa11/d11
mutant kidney at E11.5 was the homeobox gene Irx3, which
was up-regulated 6-fold. It is quite interesting that earlier
experiments have shown that Irx3 is also a downstream target of
both Hoxa9 and Hoxa10 in hematopoietic cells (Ferrell et al.,
2005). The Hox9, 10 and 11 paralogous groups are all very
closely related Abd-b type Hox genes, and it is not surprising to
see overlap in their downstream targets. In yet another study,
looking at development of the hindbrain, it was shown that over
expression of Hoxa3, a more distant relative of the Hox11
genes, caused repression of Irx3 transcription (Guidato et al.,
2003). These previous connections between Hox genes and Irx3
support the conclusion that Irx3 is a true downstream effector of
Hoxa11/d11 in the developing kidney. It is also interesting that
these different Hox genes would share this same target in these
different developing systems, although again this is perhaps not
surprising in light of the similarities of their DNA bindinghomeodomains. As multiple targets for multiple Hox genes are
unveiled we gain a deeper understanding of Hox functional
relationships.
The functions of Irx3 in kidney development remain
uncertain. Irx3 has been shown to be capable of regulating
competence to respond to hedgehog signaling in the nervous
system (Kiecker and Lumsden, 2004). It has also been shown
that Irx3 expression can be directed by Wnt signaling in the
nervous system (Braun et al., 2003). These observations suggest
a possible connection between Irx3 and growth factor signaling
in the developing kidney. It has also been previously shown that
Irx3 is expressed in the normal developing kidney, but primarily
in a more mature structure, the forming glomerulus (Houweling
et al., 2001).
The gene with the second greatest fold change in the
Hoxa11/d11 mutant kidneys at E11.5 was Slc40a1, an iron
exporter also known as Ferroportin1. On two separate probe sets
this gene showed down-regulation of −5.2 and −6.1. This is an
especially intriguing observation because of the known
importance of iron in kidney development. When growing
kidneys in organ culture it is necessary to add Fe3+-transferrin to
minimal essential media to promote robust branching morpho-
genesis of the UB and nephrogenesis of the MM (Landschulz
and Ekblom, 1985). Furthermore, another iron transporter,
lipocalin, also known as NGAL, has been shown to be an
important inducer of nephrogenesis secreted by the UB (Yang et
al., 2003). This established connection between iron levels and
nephrogenesis, and our observation that the expression of the
Ferroportin1 gene is significantly down-regulated in the
mutants, suggests that one molecular mechanism of function
of Hoxa11 and Hoxd11 in kidney development might be
through the regulation of intracellular iron levels.
Two other genes showed a more than 3-fold down-regulation
in the E11.5 mutant MM. Prkcn, a member of the protein kinase
C family, showed a 4.5-fold reduction in mutants. It has been
previously shown that a number of PKC inhibitors disturb
nephron formation and inhibit growth of kidneys in organ
culture (Yang et al., 2003). It is interesting that the inhibition of
PKC gives a phenotype resembling that produced by Hoxa11/
d11 mutation.
The homeobox gene Meox2 (also named Gax) was down-
regulated 3.4-fold in the E11.5 mutant kidney. Previous studies
have demonstrated that over-expression of Meox2 can reduce
cell proliferation rates (Fisher et al., 1997; Smith et al., 1997).
This seems somewhat paradoxical, since the mutant kidney
shows reduced Meox2 expression, and reduced size. The
Meox2 gene has also been connected to regulation of cell
migration and integrin expression (Perlman et al., 1999).
Our E12.5/13.5 data provided further evidence that Meox2
is a genuine downstream target of Hoxa11/Hoxd11 in kidney
development. The Affymetrix microarray data also found a
significant decrease in Meox2 expression in the mutants at
this later stage (−3.5-fold change). Real time PCR validation
confirmed this difference at E13.5 (−5.7-fold change, data not
shown). The Illumina microarrays also detected an expression
change in this gene (−3.0-fold), but the observed P value of
0.11 did not make the <0.05 cutoff, so Meox2 was not
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at this later stage.
Several other genes of interest showed altered expression in
the E11.5 mutant kidneys, including tropomyosin 2 beta (−2.7-
fold, −2.7, and −2.5 on three separate probe sets), an important
component of the cytoskeleton, Wsb1 (−2.6-fold), a hedgehog
inducible ubiquitin ligase (Dentice et al., 2005), and shoc2
(−2.5-fold), a gene involved in fibroblast growth factor receptor
signaling (Selfors et al., 1998). Other genes that showed lower
fold changes included Zhx1 (−1.5-fold) a zinc finger-homeobox
gene that is induced by cytokines (Shou et al., 2004), Sall2
(−1.6), Foxc2 (−2.0), which has been shown to have an
important role in kidney development (Kume et al., 2000a),
Rab24 (−1.7), a member of the Ras oncogene family, and
Rassf1 (−2.0, −2.1) a Ras associated domain family member.
At E12.5/13.5 the gene showing the greatest up-regulation
encodes the transcription factor Gata6 (3.6- and 3.0-fold change
on two separate probe sets). This is particularly interesting
because over expression of Gata6 has been previously shown to
cause growth arrest, in both vascular myocytes and glomerular
mesangial cells (Nagata et al., 2000), correlating nicely with the
observed reduced size of the Hoxa11/d11 mutant kidney.
Interestingly, four members of the TGF-beta pathway were
also up-regulated at E12.5/13.5, including Tgfb2 (3.6-fold),
Smad6 (2.8), Ltbp1 (2.7), and fibrillin (2.5, 2.0). Several
previous studies have shown the importance of TGF signaling
in kidney development. Tgfb2 has been shown to be expressed
in both the MM and UB, and can induce nephrogenesis when
added to MM culture along with FGF2 (Plisov et al., 2001). The
Tgfb2 knockout mouse shows a renal agenesis phenotype, with
incomplete penetrance (Sanford et al., 1997). A conditional
MM knockout of Smad4, the downstream activator of TGF-beta
signaling, results in abnormal nephrogenesis (Oxburgh et al.,
2004). Smad6, an inhibitory Smad, interacts downstream of
TGF-beta signals to negatively regulate transcription activation,
and interestingly is specifically expressed in the nephrogenic
mesenchyme and UB tips of the developing kidney (Vrljicak et
al., 2004). The Fibrillin1 and Ltbp1 genes encode structurally
related proteins. TGF-beta is secreted as a latent complex that
includes the latent TGF-beta binding protein (Ltbp1) (Annes et
al., 2003). The Fibrillin1 protein is a matrix component of the
extracellular microfibrils and plays an important role in TGF-
beta activation (Neptune et al., 2003). This observed dysregula-
tion of expression of Tgfb2, Smad6, Ltbp1 and fibrillin1
suggests an important role for Hox11 genes in the control of
TGF-beta signaling in the developing kidney.
Other notable genes up-regulated in the HoxA11/D11 mutant
E12.5/E13.5 kidneys include, Cxcl12 (3.3-fold), Ldb1 (1.9),
Slit3 (2.3), and Robo4 (2.2). Cxcl12 is a small, c–x–c motif
chemokine that is expressed in comma and s-shaped bodies
during nephrogenesis and within the mesangium of the
maturing glomeruli (Grone et al., 2002). Lbd1 is a cofactor
that can interact with many transcription factors, including
LIM-homeodomain proteins such Lhx1, which is required for
both normal UB branching morphogenesis and developmental
progression of the renal vesicle during nephrogenesis (Kobaya-
shi et al., 2005). Lbd1 can increase or decrease transcriptionfactor activity, with correct Lbd1-LIMHD stoichiometry
essential for normal development (Neptune et al., 2003).
Overexpression of Ldb1 has been associated with a block of
differentiation in both immature erythroid cells and mammary
epithelial cells (Visvader et al., 1997, 2001). Slit2 and its
receptor Robo2 have been shown to restrict GDNF expression
in the intermediate mesoderm thereby restricting the site of the
UB formation (Grieshammer et al., 2004). Slit3 and/or Robo4
may have similar roles in repression of GDNF expression. The
microarray observed over expression of Slit3 and Robo4 would
then be predicted to result in reduced levels of GDNF, and this
was indeed found. The level of down-regulation was, however,
only 1.3-fold, and therefore not sufficient to make the 1.5-fold
cutoff used to make the list of differently expressed genes.
These results suggest, but do not prove, that the previously
observed loss of GDNF expression in Hox11 triple mutants
(Hoxa11, Hoxc11, Hoxd11) (Wellik et al., 2002) might be
mediated through increased Slit–Robo expression.
In conclusion, the microarray analysis of a mutant phenotype
can be challenging, yet highly rewarding. By examining the
early stages of a developmental abnormality, one defines the
initiating events, but the differences present between wild type
and mutant at this point might be subtle, with many genes
showing small changes in expression. In order to obtain
convincing results, we found it necessary to use 17 microarrays
to compare E12.5/E13.5 wild type and mutant, and then another
17 microarrays to compare E11.5. The initial analysis was
performed with Affymetrix microarrays. We found that the use
of a second microarray platform, Illumina, with independent
biological samples, provided a high throughput validation that
effectively separated genuine differences from artifacts.
The results of this study identify multiple Hox11 effectors in
kidney development. Many of the genes with altered expression
make sense. The gene with the greatest up-regulation at E11.5,
Irx3, has been previously identified as a downstream target of
three other Hox genes. In addition, the up-regulation of Gata6,
the perturbation of iron transport, PKC levels, TGF-beta
signaling, Lbd1, Slit and Robo all fit with the observed kidney
phenotype of reduced size, reduced branching morphogenesis
and altered MM–UB interactions. As more microarray studies
are performed on more Hox mutants, in both kidney and other
tissues, we will gain deeper insight into the molecular
mechanisms of Hox function and the extent of Hox functional
overlap.
Acknowledgments
We thank Michael Bennett for help with embryo block
preparation, discussions regarding RT-PCR validations, and
careful reading of the manuscript. We thank Kristen Saletel and
Shawn Smith for generation of microarray data. This work was
supported by NIH grant 1RO1DK61916.
Appendix A. Supplementary data
Supplementary data associated with this article can be found
in the online version at doi:10.1016/j.ydbio.2006.02.023.
552 K. Schwab et al. / Developmental Biology 293 (2006) 540–554ReferencesAnnes, J.P., Munger, J.S., Rifkin, D.B., 2003. Making sense of latent TGFbeta
activation. J. Cell Sci. 116, 217–224.
Basson, M.A., Akbulut, S., Watson-Johnson, J., Simon, R., Carroll, T.J., Shakya,
R., Gross, I., Martin, G.R., Lufkin, T., McMahon, A.P., Wilson, P.D.,
Costantini, F.D.,Mason, I.J., Licht, J.D., 2005. Sprouty1 is a critical regulator
of GDNF/RET-mediated kidney induction. Dev. Cell 8, 229–239.
Bolstad, B.M., Irizarry, R.A., Astrand, M., Speed, T.P., 2003. A comparison of
normalization methods for high density oligonucleotide array data based on
variance and bias. Bioinformatics 19, 185–193.
Bouchard, M., 2004. Transcriptional control of kidney development.
Differentiation 72, 295–306.
Brandenberger, R., Schmidt, A., Linton, J., Wang, D., Backus, C., Denda, S.,
Muller, U., Reichardt, L.F., 2001. Identification and characterization of a
novel extracellular matrix protein nephronectin that is associated with
integrin alpha8beta1 in the embryonic kidney. J. Cell Biol. 154,
447–458.
Braun, M.M., Etheridge, A., Bernard, A., Robertson, C.P., Roelink, H., 2003.
Wnt signaling is required at distinct stages of development for the induction
of the posterior forebrain. Development 130, 5579–5587.
Brunskill, E.W., Witte, D.P., Yutzey, K.E., Potter, S.S., 2001. Novel cell lines
promote the discovery of genes involved in early heart development. Dev.
Biol. 235, 507–520.
Candia, A.F., Hu, J., Crosby, J., Lalley, P.A., Noden, D., Nadeau, J.H., Wright,
C.V., 1992. Mox-1 and Mox-2 define a novel homeobox gene subfamily and
are differentially expressed during early mesodermal patterning in mouse
embryos. Development 116, 1123–1136.
Carroll, T.J., Park, J.S., Hayashi, S., Majumdar, A., McMahon, A.P., 2005.
Wnt9b plays a central role in the regulation of mesenchymal to epithelial
transitions underlying organogenesis of the Mammalian urogenital system.
Dev. Cell 9, 283–292.
Challen, G.A., Martinez, G., Davis, M.J., Taylor, D.F., Crowe, M., Teasdale,
R.D., Grimmond, S.M., Little, M.H., 2004. Identifying the molecular
phenotype of renal progenitor cells. J. Am. Soc. Nephrol. 15,
2344–2357.
Challen, G., Gardiner, B., Caruana, G., Kostoulias, X., Martinez, G., Crowe, M.,
Taylor, D.F., Bertram, J., Little, M., Grimmond, S.M., 2005. Temporal and
spatial transcriptional programs in murine kidney development. Physiol.
Genomics 23, 159–171.
Cho, E.A., Patterson, L.T., Brookhiser,W.T.,Mah, S., Kintner, C., Dressler, G.R.,
1998. Differential expression and function of cadherin-6 during renal
epithelium development. Development 125, 803–812.
Davies, J.A., Bard, J.B., 1998. The development of the kidney. Curr. Top. Dev.
Biol. 39, 245–301.
Davis, A.P., Witte, D.P., Hsieh-Li, H.M., Potter, S.S., Capecchi, M.R., 1995.
Absence of radius and ulna in mice lacking hoxa-11 and hoxd-11. Nature
375, 791–795.
Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christoffolete,
M.A., Kim, B.W., Nissim, S., Mornon, J.P., Zavacki, A.M., Zeold, A.,
Capelo, L.P., Curcio-Morelli, C., Ribeiro, R., Harney, J.W., Tabin, C.J.,
Bianco, A.C., 2005. The Hedgehog-inducible ubiquitin ligase subunit
WSB-1 modulates thyroid hormone activation and PTHrP secretion in the
developing growth plate. Nat. Cell Biol. 7, 698–705.
Durbec, P., Marcos-Gutierrez, C.V., Kilkenny, C., Grigoriou, M., Wartiowaara,
K., Suvanto, P., Smith, D., Ponder, B., Costantini, F., Saarma, M., et al.,
1996. GDNF signalling through the Ret receptor tyrosine kinase. Nature
381, 789–793.
Enomoto, H., Araki, T., Jackman, A., Heuckeroth, R.O., Snider, W.D., Johnson
Jr., E.M., Milbrandt, J., 1998. GFR alpha1-deficient mice have deficits in the
enteric nervous system and kidneys. Neuron 21, 317–324.
Fan, Q.W., Kadomatsu, K., Uchimura, K., Muramatsu, T., 1998. Embigin/
basigin subgroup of the immunoglobulin superfamily: different modes
of expression during mouse embryogenesis and correlated expression
with carbohydrate antigenic markers. Dev. Growth Differ. 40,
277–286.
Ferrell, C.M., Dorsam, S.T., Ohta, H., Humphries, R.K., Derynck, M.K., Haqq,C., Largman, C., Lawrence, H.J., 2005. Activation of stem-cell specific
genes by HOXA9 and HOXA10 homeodomain proteins in CD34+ human
cord blood cells. Stem Cells 23, 644–655.
Fisher, S.A., Siwik, E., Branellec, D., Walsh, K., Watanabe, M., 1997. Forced
expression of the homeodomain protein Gax inhibits cardiomyocyte
proliferation and perturbs heart morphogenesis. Development 124,
4405–4413.
Grieshammer, U., Le, M., Plump, A.S., Wang, F., Tessier-Lavigne, M., Martin,
G.R., 2004. SLIT2-mediated ROBO2 signaling restricts kidney induction to
a single site. Dev. Cell 6, 709–717.
Grone, H.J., Cohen, C.D., Grone, E., Schmidt, C., Kretzler, M., Schlondorff, D.,
Nelson, P.J., 2002. Spatial and temporally restricted expression of
chemokines and chemokine receptors in the developing human kidney. J.
Am. Soc. Nephrol. 13, 957–967.
Guidato, S., Prin, F., Guthrie, S., 2003. Somatic motoneurone specification in
the hindbrain: the influence of somite-derived signals, retinoic acid and
Hoxa3. Development 130, 2981–2996.
Hatini, V., Huh, S.O., Herzlinger, D., Soares, V.C., Lai, E., 1996. Essential role
of stromal mesenchyme in kidney morphogenesis revealed by targeted
disruption of Winged Helix transcription factor BF-2. Genes Dev. 10,
1467–1478.
Houweling, A.C., Dildrop, R., Peters, T., Mummenhoff, J., Moorman, A.F.,
Ruther, U., Christoffels, V.M., 2001. Gene and cluster-specific expression of
the Iroquois family members during mouse development. Mech. Dev. 107,
169–174.
Hsieh-Li, H.M., Witte, D.P., Weinstein, M., Branford, W., Li, H., Small, K.,
Potter, S.S., 1995. Hoxa 11 structure, extensive antisense transcription, and
function in male and female fertility. Development 121, 1373–1385.
Itaranta, P., Lin, Y., Perasaari, J., Roel, G., Destree, O., Vainio, S., 2002. Wnt-6
is expressed in the ureter bud and induces kidney tubule development in
vitro. Genesis 32, 259–268.
Kalatzis, V., Sahly, I., El-Amraoui, A., Petit, C., 1998. Eya1 expression in the
developing ear and kidney: towards the understanding of the pathogenesis of
Branchio-Oto-Renal (BOR) syndrome. Dev. Dyn. 213, 486–499.
Kiecker, C., Lumsden, A., 2004. Hedgehog signaling from the ZLI regulates
diencephalic regional identity. Nat. Neurosci. 7, 1242–1249.
Kispert, A., Vainio, S., McMahon, A.P., 1998. Wnt-4 is a mesenchymal signal
for epithelial transformation of metanephric mesenchyme in the developing
kidney. Development 125, 4225–4234.
Klein, G., Langegger, M., Goridis, C., Ekblom, P., 1988. Neural cell adhesion
molecules during embryonic induction and development of the kidney.
Development 102, 749–761.
Kobayashi, A., Kwan, K.M., Carroll, T.J., McMahon, A.P., Mendelsohn, C.L.,
Behringer, R.R., 2005. Distinct and sequential tissue-specific activities of
the LIM-class homeobox gene Lim1 for tubular morphogenesis during
kidney development. Development 132, 2809–2823.
Kreidberg, J.A., Sariola, H., Loring, J.M., Maeda, M., Pelletier, J., Housman, D.,
Jaenisch, R., 1993. WT-1 is required for early kidney development. Cell 74,
679–691.
Kume, T., Deng, K., Hogan, B.L., 2000a. Minimal phenotype of mice
homozygous for a null mutation in the forkhead/winged helix gene, Mf2.
Mol. Cell. Biol. 20, 1419–1425.
Kume, T., Deng, K., Hogan, B.L., 2000b. Murine forkhead/winged helix genes
Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of
the kidney and urinary tract. Development 127, 1387–1395.
Labastie, M.C., Catala, M., Gregoire, J.M., Peault, B., 1995. The GATA-3 gene
is expressed during human kidney embryogenesis. Kidney Int. 47,
1597–1603.
Landschulz, W., Ekblom, P., 1985. Iron delivery during proliferation and
differentiation of kidney tubules. J. Biol. Chem. 260, 15580–15584.
Lim, K.C., Lakshmanan, G., Crawford, S.E., Gu, Y., Grosveld, F., Engel,
J.D., 2000. Gata3 loss leads to embryonic lethality due to
noradrenaline deficiency of the sympathetic nervous system. Nat.
Genet. 25, 209–2012.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T)) method.
Methods 25, 402–408.
Loughna, S., Hardman, P., Landels, E., Jussila, L., Alitalo, K., Woolf, A.S.,
553K. Schwab et al. / Developmental Biology 293 (2006) 540–5541997. A molecular and genetic analysis of renalglomerular capillary
development. Angiogenesis 1, 84–101.
Majumdar, A., Vainio, S., Kispert, A., McMahon, J., McMahon, A.P., 2003.
Wnt11 and Ret/Gdnf pathways cooperate in regulating ureteric
branching during metanephric kidney development. Development 130,
3175–3185.
Miyamoto, N., Yoshida, M., Kuratani, S., Matsuo, I., Aizawa, S., 1997. Defects
of urogenital development in mice lacking Emx2. Development 124,
1653–1664.
Miyazaki, Y., Oshima, K., Fogo, A., Hogan, B.L., Ichikawa, I., 2000. Bone
morphogenetic protein 4 regulates the budding site and elongation of the
mouse ureter. J. Clin. Invest. 105, 863–873.
Moore, M.W., Klein, R.D., Farinas, I., Sauer, H., Armanini, M., Phillips,
H., Reichardt, L.F., Ryan, A.M., Carver-Moore, K., Rosenthal, A., 1996.
Renal and neuronal abnormalities in mice lacking GDNF. Nature 382,
76–79.
Muller, U., Wang, D., Denda, S., Meneses, J.J., Pedersen, R.A., Reichardt,
L.F., 1997. Integrin alpha8beta1 is critically important for epithelial–
mesenchymal interactions during kidney morphogenesis. Cell 88,
603–613.
Nagata, D., Suzuki, E., Nishimatsu, H., Yoshizumi, M., Mano, T., Walsh, K.,
Sata, M., Kakoki, M., Goto, A., Omata, M., Hirata, Y., 2000. Cyclin A
downregulation and p21(cip1) upregulation correlate with GATA-6-
induced growth arrest in glomerular mesangial cells. Circ. Res. 87,
699–704.
Nagy, A., 2003. Manipulating the Mouse Embryo: A Laboratory Manual. Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
Neptune, E.R., Frischmeyer, P.A., Arking, D.E., Myers, L., Bunton, T.E.,
Gayraud, B., Ramirez, F., Sakai, L.Y., Dietz, H.C., 2003. Dysregulation of
TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat.
Genet. 33, 407–411.
Nishinakamura, R., Matsumoto, Y., Nakao, K., Nakamura, K., Sato, A.,
Copeland, N.G., Gilbert, D.J., Jenkins, N.A., Scully, S., Lacey, D.L.,
Katsuki, M., Asashima, M., Yokota, T., 2001. Murine homolog of SALL1 is
essential for ureteric bud invasion in kidney development. Development
128, 3105–3115.
Oliver, G., Wehr, R., Jenkins, N.A., Copeland, N.G., Cheyette, B.N.,
Hartenstein, V., Zipursky, S.L., Gruss, P., 1995. Homeobox genes and
connective tissue patterning. Development 121, 693–705.
Oxburgh, L., Chu, G.C., Michael, S.K., Robertson, E.J., 2004. TGFbeta
superfamily signals are required for morphogenesis of the kidney
mesenchyme progenitor population. Development 131, 4593–4605.
Patterson, L.T., Potter, S.S., 2004. Atlas of Hox gene expression in the
developing kidney. Dev. Dyn. 229, 771–779.
Patterson, L.T., Pembaur, M., Potter, S.S., 2001. Hoxa11 and Hoxd11 regulate
branching morphogenesis of the ureteric bud in the developing kidney.
Development 128, 2153–2161.
Perlman, H., Luo, Z., Krasinski, K., Le Roux, A., Mahfoudi, A., Smith, R.C.,
Branellec, D., Walsh, K., 1999. Adenovirus-mediated delivery of the Gax
transcription factor to rat carotid arteries inhibits smooth muscle
proliferation and induces apoptosis. Gene Ther. 6, 758–763.
Pichel, J.G., Shen, L., Sheng, H.Z., Granholm, A.C., Drago, J., Grinberg, A.,
Lee, E.J., Huang, S.P., Saarma, M., Hoffer, B.J., Sariola, H., Westphal, H.,
1996. Defects in enteric innervation and kidney development in mice
lacking GDNF. Nature 382, 73–76.
Piper, M., Georgas, K., Yamada, T., Little, M., 2000. Expression of the
vertebrate Slit gene family and their putative receptors, the Robo genes, in
the developing murine kidney. Mech. Dev. 94, 213–217.
Plisov, S.Y., Yoshino, K., Dove, L.F., Higinbotham, K.G., Rubin, J.S.,
Perantoni, A.O., 2001. TGF beta 2, LIF and FGF2 cooperate to induce
nephrogenesis. Development 128, 1045–1057.
Quaggin, S.E., Schwartz, L., Cui, S., Igarashi, P., Deimling, J., Post, M.,
Rossant, J., 1999. The basic-helix–loop–helix protein pod1 is critically
important for kidney and lung organogenesis. Development 126,
5771–5783.
Rozen, S., Skaletsky, H., 2000. Primer3 on the WWW for general users and for
biologist programmers. Methods Mol. Biol. 132, 365–386.
Ryan, G., Steele-Perkins, V., Morris, J.F., Rauscher III, F.J., Dressler, G.R.,1995. Repression of Pax-2 by WT1 during normal kidney development.
Development 121, 867–875.
Sanchez, M.P., Silos-Santiago, I., Frisen, J., He, B., Lira, S.A., Barbacid, M.,
1996. Renal agenesis and the absence of enteric neurons in mice lacking
GDNF. Nature 382, 70–73.
Sanford, L.P., Ormsby, I., Gittenberger-de Groot, A.C., Sariola, H., Friedman,
R., Boivin, G.P., Cardell, E.L., Doetschman, T., 1997. TGFbeta2
knockout mice have multiple developmental defects that are non-
overlapping with other TGFbeta knockout phenotypes. Development
124, 2659–2670.
Saxen, L., Lehtonen, E., 1987. Embryonic kidney in organ culture.
Differentiation 36, 2–11.
Schmidt-Ott, K.M., Yang, J., Chen, X., Wang, H., Paragas, N., Mori, K., Li, J.Y.,
Lu, B., Costantini, F., Schiffer, M., Bottinger, E., Barasch, J., 2005. Novel
regulators of kidney development from the tips of the ureteric bud. J. Am.
Soc. Nephrol. 16, 1993–2002.
Schnabel, C.A., Godin, R.E., Cleary, M.L., 2003. Pbx1 regulates
nephrogenesis and ureteric branching in the developing kidney. Dev.
Biol. 254, 262–276.
Schuchardt, A., D'Agati, V., Larsson-Blomberg, L., Costantini, F., Pachnis, V.,
1994. Defects in the kidney and enteric nervous system of mice lacking the
tyrosine kinase receptor Ret. Nature 367, 380–383.
Schwab, K., Patterson, L.T., Aronow, B.J., Luckas, R., Liang, H.C., Potter, S.S.,
2003. A catalogue of gene expression in the developing kidney. Kidney Int.
64, 1588–1604.
Seifert, R.A., Alpers, C.E., Bowen-Pope, D.F., 1998. Expression of platelet-
derived growth factor and its receptors in the developing and adult mouse
kidney. Kidney Int. 54, 731–746.
Selfors, L.M., Schutzman, J.L., Borland, C.Z., Stern, M.J., 1998. soc-2 encodes
a leucine-rich repeat protein implicated in fibroblast growth factor receptor
signaling. Proc. Natl. Acad. Sci. U. S. A. 95, 6903–6908.
Shou, Z., Yamada, K., Kawata, H., Yokoyama, O., Miyamoto, K., 2004. A
mechanism of induction of the mouse zinc-fingers and homeoboxes 1
(ZHX1) gene expression by interleukin-2. Biochem. Biophys. Res.
Commun. 314, 885–890.
Small, K.M., Potter, S.S., 1993. Homeotic transformations and limb defects in
Hox A11 mutant mice. Genes Dev. 7, 2318–2328.
Smith, R.C., Branellec, D., Gorski, D.H., Guo, K., Perlman, H., Dedieu, J.F.,
Pastore, C., Mahfoudi, A., Denefle, P., Isner, J.M., Walsh, K., 1997.
p21CIP1-mediated inhibition of cell proliferation by overexpression of the
gax homeodomain gene. Genes Dev. 11, 1674–1689.
Stark, K.L., McMahon, J.A., McMahon, A.P., 1991. FGFR-4, a new member of
the fibroblast growth factor receptor family, expressed in the definitive
endoderm and skeletal muscle lineages of the mouse. Development 113,
641–651.
Stark, K., Vainio, S., Vassileva, G., McMahon, A.P., 1994. Epithelial
transformation of metanephric mesenchyme in the developing kidney
regulated by Wnt-4. Nature 372, 679–683.
Stuart, R.O., Bush, K.T., Nigam, S.K., 2001. Changes in global gene expression
patterns during development and maturation of the rat kidney. Proc. Natl.
Acad. Sci. U. S. A. 98, 5649–5654.
Tessarollo, L., Nagarajan, L., Parada, L.F., 1992. c-ros: the vertebrate
homolog of the sevenless tyrosine kinase receptor is tightly regulated
during organogenesis in mouse embryonic development. Development
115, 11–20.
Virtanen, I., Laitinen, L., Korhonen, M., 1995. Differential expression of
laminin polypeptides in developing and adult human kidney. J. Histochem.
Cytochem. 43, 621–628.
Visvader, J.E., Mao, X., Fujiwara, Y., Hahm, K., Orkin, S.H., 1997. The LIM-
domain binding protein Ldb1 and its partner LMO2 act as negative
regulators of erythroid differentiation. Proc. Natl. Acad. Sci. U. S. A. 94,
13707–13712.
Visvader, J.E., Venter, D., Hahm, K., Santamaria, M., Sum, E.Y., O'Reilly, L.,
White, D., Williams, R., Armes, J., Lindeman, G.J., 2001. The LIM domain
gene LMO4 inhibits differentiation of mammary epithelial cells in vitro and
is overexpressed in breast cancer. Proc. Natl. Acad. Sci. U. S. A. 98,
14452–14457.
Vrljicak, P., Myburgh, D., Ryan, A.K., van Rooijen, M.A., Mummery, C.L.,
554 K. Schwab et al. / Developmental Biology 293 (2006) 540–554Gupta, I.R., 2004. Smad expression during kidney development. Am. J.
Physiol.: Renal. Physiol. 286, F625–F633.
Wellik, D.M., Hawkes, P.J., Capecchi, M.R., 2002. Hox11 paralogous genes are
essential for metanephric kidney induction. Genes Dev. 16, 1423–1432.
Yang, J., Mori, K., Li, J.Y., Barasch, J., 2003. Iron, lipocalin, and kidney
epithelia. Am. J. Physiol.: Renal. Physiol. 285, F9–F18.
Yoshino, K., Rubin, J.S., Higinbotham, K.G., Uren, A., Anest, V., Plisov, S.Y.,Perantoni, A.O., 2001. Secreted Frizzled-related proteins can regulate
metanephric development. Mech. Dev. 102, 45–55.
Yu, J., Carroll, T.J., McMahon, A.P., 2002. Sonic hedgehog regulates
proliferation and differentiation of mesenchymal cells in the mouse
metanephric kidney. Development 129, 5301–5312.
Yu, J., McMahon, A.P., Valerius, M.T., 2004. Recent genetic studies of mouse
kidney development. Curr. Opin. Genet. Dev. 14, 550–557.
